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Abstract
Considering the dynamic nature of CYPs, methods that reveal information about substrate and
enzyme dynamics are necessary to generate predictive models. To compare substrate dynamics in
CYP2E1 and CYP2A6, intramolecular isotope effect experiments were conducted, using deuterium
labeled substrates: o-xylene, m-xylene, p-xylene, 2,6-dimethylnaphthalene, and 4,4′-
dimethylbiphenyl. Competitive intermolecular experiments were also conducted using d0- and d6-
labeled p-xylene. Both CYP2E1 and CYP2A6 displayed full isotope effect expression for o-xylene
oxidation and almost complete suppression for dimethylbiphenyl. Interestingly, (kH/kD)obs for d3-
p-xylene oxidation ((kH/kD)obs = 6.04 and (kH/kD)obs = 5.53 for CYP2E1 and CYP2A6, respectively)
was only slightly higher than (kH/kD)obs for d3-dimethylnaphthalene ((kH/kD)obs = 5.50 and (kH/
kD)obs = 4.96, respectively). One explanation is that in some instances (kH/kD)obs values are generated
by the presence of two substrates bound simultaneously to the CYP. Speculatively, if this explanation
is valid, then intramolecular isotope effect experiments should be useful in the mechanistic
investigation of P450 cooperativity.
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Some Cytochromes P450 (CYP or P450) catalyze the oxidative metabolism of exogenous
compounds, including drugs, to metabolites that are usually less toxic and more water soluble,
especially after conjugation. This process is important since it reduces the risk of drug-induced
toxicity by facilitating drug elimination. However, in certain cases, CYP-catalyzed oxidation
may also lead to the formation of reactive, electrophilic metabolites that can lead to toxicity
or carcinogenicity. Inhibition or induction of specific P450 isoforms can also be a source of
drug-drug interactions. On account of these important roles that CYPs play in drug metabolism
and drug toxicity, a substantial effort to characterize the drug-metabolizing CYPs continues
with hopes of predicting such details as isoform selectivity of new drug candidates, rates of
metabolite formation, product selectivity, and the formation of toxic metabolites.
The development of accurate predictive models requires, among other things, an understanding
of structure (both of the enzyme and the substrate), mechanism, and kinetics. With CYP
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enzymes a clear understanding of this relationship is especially challenging since there is the
additional complexity that, in many instances, a single enzyme can bind a variety of substrates,
multiple substrates, and/or generate multiple products from a single substrate. A variety of
tools have been used to investigate P450 structure including x-ray crystallography, mechanism-
based inactivators, photoaffinity labeling, site directed mutagenesis, and homology modelling.
These techniques have been effective in the identification of residues that are important for
function [1], substrate selectivity [2], product selectivity [3], and cooperative kinetics [4].
Interestingly, the static crystal structures of modified human CYPs have provided insight into
the dynamic nature of the CYPs. In some structures the substrate is positioned so far away from
the heme that some motion or translation by the substrate and/or protein is required for substrate
oxidation [5]. In other cases, the structural changes observed in comparisons of the substrate-
free versus substrate-bound structures are indicative of significant protein motion [6;7].
Therefore, considering the dynamic nature of CYPs, methods that reveal information
concerning substrate and CYP dynamics are crucial for understanding mechanisms of substrate
binding and orientation, product selectivity, multiple ligand binding, and ultimately, accurate
predictive models.
Currently there are several tools that can provide information about CYP and substrate
dynamics. CO-flash photolysis has been effective at revealing information about the overall
flexbility of P450 enzymes [8]. Fluorescence studies have also been used to investigate protein
dynamics [9;10;11]. Solid-state NMR was recently used to investigate amino acid motion upon
substrate binding in P450BM-3 [12]. A solid-state NMR method was also used to study
P450cam and provided evidence that the substrate, adamantane, undergoes rapid motion within
the P450cam active site [13]. In the current study we have used deuterium isotope effect
experiments to investigate substrate dynamics.
For more than thirty years investigators have utilized deuterium isotope effect experiments to
study CYP enzymes. Because of the mechanistic information that deuterium isotope effect
experiments can provide, initially much of this work focused on understanding the steps of
substrate oxidation (e.g., H atom abstraction versus oxygen insertion) and utilized both
intermolecular and intramolecular deuterium isotope effect experiments [14;15;16].
Stimulated by the earlier mechanistic experiments it became apparent that information about
substrate dynamics could be revealed using intramolecular isotope effect experiments that
utilize a series of symmetrical and selectively deuterium labeled substrates [17;18;19]. The
technique takes advantage of the isotope effect suppression (the masking effect) that is
observed when the rate of interchange between labeled and unlabeled regions of a molecule is
slow compared to the rate of product formation. The technique involves using a series of
symmetrical compounds like those shown in Figure 1, where one methyl group is labeled (R-
CD3) and the other is unlabeled (R-CH3) with increasing separation between the
symmetrically-related groups. Full expression of the isotope effect is expected for compounds
that can reorient rapidly in the active site (i.e., short distances between methyl groups).
However as the methyl group separation is increased the enzyme active site structure hinders
substrate reorientation and the intrinsic isotope effect is suppressed. That is, the observed
isotope effect is smaller than the intrinsic isotope effect. Theoretically, in cases of multiple
ligand binding (P450 allosterism), a second substrate could also lead to changes in substrate
dynamics and changes in the observed isotope effect [20]. Therefore, for a given CYP isoform,
the isotope effect suppression profile across the series of substrates can provide two pieces of
information. It can convey information about substrate motion, that is, the rate of interchange
between labeled and unlabeled groups, and how this rate of interchange changes with different
substrates for a single enzyme or, alternatively, how the rate of interchange changes from
isoform to isoform using an identical substrate. Secondly, in circumstances where a single
substrate binds to the enzyme it can provide an estimate of the active site area and volume
available for unhindered substrate rotation [21].
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CYP2E1 and CYP2A6 are good candidates for comparative studies that focus on the
relationship between substrate dynamics and enzyme structure. In addition to belonging to the
same CYP2 family, they share a rather broad overlap in substrate selectivity (e.g.,
dimethylnitrosamine, diethynitrosamine, p-nitrophenol, halothane, acetaminophen, and
butadiene) and both are widely assumed to have relatively small active sites because of their
preference for low molecular weight substrates [2;22;23;24;25;26;27;28;29;30;31;32]. In some
instances each enzyme displays unique product selectivity for the same substrate. For example,
with acetaminophen the predominant metabolite of CYP2E1 mediated oxidation is N-acetyl-
p-quinoneimine (NAPQI). Meanwhile, CYP2A6 predominantly catalyzes the formation of the
relatively non-toxic catechol [33]. In the work presented here, the CYP2E1 and CYP2A6 active
sites were probed using symmetrical intramolecular and competitive intermolecular isotope
effect experiments in order to assess substrate dynamics and the active site space of these
isoforms. We also hoped to identify some significant differences in the kH/kD suppression
profile that could be exploited in the future using a combination of reciprocal mutagenesis and
isotope effect experiments to identify active site residues that affect substrate dynamics.
Materials and methods
o-Xylene-α-2H3, 4-2H3,4′-dimethylbiphenyl, and 2-2H3,6-dimethylnaphthalene were
synthesized as described previously [18;21]. Supersomes™ (human CYP2E1 and human
CYP2A6 with P450 reductase and cytochrome b5) and insect cell control microsomes were
from BD Gentest. p-Xylene, p-xylene-α, α, α, α ′, α ′, α ′ -d6, methyl 3-methylbenzoate, methyl
4-methylbenzoate, lithium aluminum deuteride (LAD), methanesulfonyl chloride, N,N-
diisopropylethylamine (EDIPA), pentane, BSTFA, and NADPH, were purchased from Sigma-
Aldrich. Methanol was purchased from Fisher. DB-5 gas chromatography capillary column
was from J&W Scientific, (Folsom, CA). Econosil C18 column was purchased from Alltech.
Synthesis and Characterization of p-Xylene-α-2H3
This compound was synthesized and purified as described previously [18] with minor changes.
Methyl 4-methylbenzoate (7.6 g, 0.05 mol) in ether was added dropwise to LAD (2.4 g, 0.05
mol) suspended in ether and magnetically stirred overnight under nitrogen, at room
temperature. The reaction was quenched cautiously with 1 mL water, 2 mL 15% NaOH, and
then again with water to ensure complete decomposition. The reaction mixture was filtered
and extracted several times with pentane. The combined pentane layers were dried with sodium
sulfate and then evaporated and dried further in vacuo to yield white needle-like crystals of p-
methylbenzylalcohol (5.5 g, 0.045 mol, 90% yield, m.p. = 56–59 °C). A portion of the alcohol
(3.2 g, 0.026 mol) was stirred overnight with methane sulfonylchloride (6.4 g, 0.056 mol) in
150 mL dichloromethane containing 16.5 mL EDIPA. The reaction mixture was washed two
times with 150 mL water and two times with 150 mL saturated sodium bicarbonate. The organic
layer was dried with sodium sulfate and evaporated. The mesylate was purified on an alumina
column (2.5 cm × 44 cm, activated, neutral, Brockman I) with pentane as the elution solvent.
Pentane was removed by rotoevaporation to yield the pure p-methylbenzyl mesylate (faint
yellow oil, 2.4 g, 0.012 mol, 45% yield). The mesylate (1.3 g, 0.0062 mol) was dissolved in
25 mL dry tetrahydrofuran (THF) and added dropwise to LAD (0.28 g, 0.0067 mol) suspended
in 10 mL THF and then magnetically stirred overnight with gentle reflux and a nitrogen soft
cap. The reaction was quenched as described above for the alcohol, extracted with pentane,
and dried with sodium sulfate. The xylene was transferred to a flask equipped with a water-
cooled condenser, placed in a dry ice/isopropyl alcohol bath and then concentrated with a
stream of air. The p-xylene-α-2H3 was purified on an alumina column (2.5 cm × 21.5 cm) using
pentane, which was distilled off to yield the pure compound (0.50 g, 0.0046 mol, 75% yield).
The xylene was > 99% pure by GC-MS and had a deuterium content of 97.77 atom %
deuterium-d3, 1.60 atom % deuterium-d2, and 0.20 atom % deuterium-d1, and 0.54% atom %
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deuterium-d0. Reactions were monitored using HPLC (Econosil C18, 5μ, 4.6 × 250 mm, 85%
acetonitrile-water mixture, 1 mL/min) and standards of unlabeled compounds.
Synthesis and Characterization of m-Xylene-α-2H3
This compound was synthesized following the method described for p-xylene-α-2H3. The
xylene was > 99% pure by GC-MS and had a deuterium content of 94.70 atom % deuterium-
d3, 4.51 atom % deuterium-d2, 0.08 atom % deuterium-d1, and 0.70 atom % deuterium-d0.
Determination of Intramolecular Deuterium Isotope Effects for the Benzylic Hydroxylation of
o-Xylene-α-2H3, m-Xylene-α-2H3, p-Xylene-α-2H3, 2-2H3,6-Dimethylnaphthalene, 4-2H3,4′-
Dimethylbiphenyl
Incubations contained 50 pmol CYP2E1 or CYP2A6 Supersomes in 50 mM potassium
phosphate buffer (pH = 7.4). Substrate (1 mM in methanol) was added except for the biphenyl
compound which was added to a final concentration of 0.5 mM. Total methanol concentration
ranged from 0.8% to 1.3% (v/v). P450, buffer and substrate were pre-incubated for five minutes
at 37 °C and the reaction initiated by the addition of NADPH (final concentration = 1 mM).
The incubations proceeded for 30 minutes and were terminated and extracted twice with 3 mL
of ice-cold pentane. The pentane layers were combined and dried with magnesium sulfate. The
magnesium sulfate was removed by centrifugation and the pentane layers were evaporated to
approximately 30 μL with dry N2. Derivatization of the hydroxyl metabolites was achieved by
the addition of 100 μL BSTFA/ethyl acetate (1:1) and heating at 50 °C for 30 minutes. The
derivatized samples were then analyzed by GC-MS. An example of a typical chromatogram is
displayed (Figure 2).
Determination of Deuterium Isotope Effects for the Benzylic Hydroxylation of p-Xylene Using
a Competitive Intermolecular Design
Incubation conditions and analysis were the same as for the intramolecular experiments except
that substrate consisted of a 1:1 mixture of unlabeled (d0) and labeled (d6; both methyl groups
labeled) p-xylene which was added to a final total xylene concentration of 1 mM.
Quantification of Metabolic Switching for the Hydroxylation of m-Xylene-α-2H3
The products of m-xylene oxidation (m-methylbenzylalcohol and 2,4-dimethylphenol) were
quantified using p-methylbenzylalcohol as an internal standard which was added just prior to
pentane extraction. A typical standard curve for these two compounds is provided in the
supplemental material. The interday coefficient of variation was < 3% for m-
methylbenzylalcohol detection (250 pmol/mL) and < 9% for 2,4-dimethylphenol detection (50
pmol/mL).
GC-MS Analysis
Derivatized metabolites were analyzed with a Finnigan Trio 1000 mass spectrometer interfaced
with a Hewlett-Packard 5890 GC equipped with a DB-5 capillary column (30 m). The column
head pressure was set at 5 psi with helium used as the carrier gas. The mass spectrometer was
operated in the electron impact mode (EI) at −70 eV electron energy with source and interface
temperatures set at 200 °C and 250 °C, respectively. To determine the deuterium incorporation
for the substrates the ionization energy was set to −12.5 eV and the GC conditions were as
reported previously [18;21] except for m-and p-xylene which were injected at an oven
temperature of 50 °C and held at a constant temperature for five minutes. Ions were detected
in the selected ion monitoring mode (SIM). Xylene metabolites were injected on the column
at an oven temperature of 40 °C, held at constant temperature for 1 minute, and eluted with a
linear gradient of 3 °C/min to 180 °C. The naphthyl and biphenyl compounds were injected at
an oven temperature of 130 °C, held at a constant temperature for one minute, and eluted with
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a linear temperature gradient of 5 °C/min to 270 °C. Monitored ions corresponded to the
[M-15]+ fragments generated from the trimethylsilated hydroxyl metabolites. Confirmation of
the metabolite retention times was accomplished by comparison to the retention times of
synthetic or commercially available standards. Isotope effect values were calculated using the
peak areas of the appropriate ions. Corrections for natural isotopic abundance and incomplete
deuterium incorporation were made as previously described [18].
Results
Comparison of Intramolecular Isotope Effects for CYP2E1 and CYP2A6
The observed intramolecular isotope effects for the CYP2E1 and CYP2A6 mediated
hydroxylation of a series of symmetrical, selectively deuterium-labeled substrates are
presented in Table 1. The observed isotope effect is a combination of one primary isotope effect
and two secondary isotope effects (PS2). The trend in isotope effect suppression was similar
for both enzymes: full kH/kD expression with o-xylene, partial suppression with m-xylene, p-
xylene, and dimethylnaphthalene, and significant suppression for the biphenyl substrate. One
noted difference between the isoforms was the incomplete suppression observed with oxidation
of the biphenyl substrate when hydroxylated by CYP2E1 ((kH/kD)obs = 2.28 ± 0.18); the
intrinsic isotope effect for this substrate was completely suppressed when submitted to
CYP2A6 mediated hydroxylation ((kH/kD)obs = 1.07 ± 0.07). Interestingly, for both enzymes,
the degree of suppression observed for the dimethylnaphthalene substrate was not profoundly
different from the isotope effect suppression observed for p-xylene even though this
corresponds to a rather significant difference in distance between unlabeled and labeled methyl
groups.
Quantitation of Branching Observed with m-Xylene
Metabolic switching was observed for m-xylene hydroxylation by both isoforms. Switching
(i.e., from benzylic hydroxylation to aromatic hydroxylation) was not observed for any of the
other substrates. The degree of switching was quantified and is presented in Table 2. The
benzylic alcohol was still the major product for both enzymes but the phenol contributed more
significantly to the total product formed by CYP2A6 (16.4% total product) than by CYP2E1
(3.1%).
Intermolecular Competitive Experiment
Results for the intermolecular competitive experiment using unlabeled p-xylene and p-xylene-
α, α, α, α ′, α ′, α ′ -d6 are presented in Table 3. The strength of the intramolecular isotope effect
experimental design that is used in this study relies on the assumption that the substrate is
reorienting in the active site. However, theoretically, it is not necessary that a substrate reorient
within the active site in order for labeled and unlabeled methyl groups to interchange. An
alternative scenario is that the substrate may associate and dissociate rapidly from the enzyme
[34;35]. In order to test which model is pertinent in the current system a competitive
intermolecular experiment was conducted. In a competitive intermolecular experiment a 1:1
mixture of the labeled (d6) and unlabeled (d0) substrate is incubated with the enzyme. If
substrate association and dissociation rates are rapid relative to the oxidative event then an
isotope effect should be observed since the enzyme ‘will choose’ the substrate that is
energetically more readily oxidized. However, if association/dissociation is slow relative to
the oxidative event then no isotope effect should be observed ((kH/kD)obs = 1). Using labeled
(d6) and unlabeled (d0) p-xylene as the substrate it is apparent that the rapid interconvertible
model (rapid reorientation within the active site) is applicable for p-xylene interactions with
both CYP2E1 and CYP2A6 as no isotope effect was observed for this substrate mixture.
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Discussion
Considering the kinetic complexities of some substrate-CYP complexes and the dynamic
nature of CYPs, a combination of methods is necessary to reveal the mechanisms of substrate
binding. That is, static methods, such as site-directed mutagensis and x-ray crystallography,
are valuable tools in identifying residues that have a role in determining product selectivity
and enzyme activity. In addition, dynamic methods are required to provide direct information
about a given residue’s effect on the actual motion of a substrate in the active site. Therefore,
with this study we hoped to identify differences in substrate dynamics for CYP2E1 and
CYP2A6; these differences could then be exploited using reciprocal mutagenesis in the future,
to identify specific residues that impact not only product selectivity but also rates of substrate
reorientation. Recently, a similar experimental approach was used effectively to elucidate the
influence of phenylalanine 87 on substrate dynamics in P450BM-3 [36].
Substrate dynamics were assessed by determining the observed intramolecular deuterium
isotope effects associated with the benzylic hydroxylation of symmetrical, selectively
deuterium labeled substrates. The extent to which the intrinsic isotope effect is expressed is
dependent on the rate of reorientation of the substrates. In other words, rapid interchange
between the labeled and unlabeled sites will lead to full expression of the intrinsic isotope
effect. On the other hand, if the rate of reorientation is decreased (i.e., reduced rotational and/
or translation motion), for example, by the residues that line the active site, then the intrinsic
isotope effect will be suppressed.
It is clear from the high isotope effects observed with o-xylene that the interchange between
labeled and unlabeled methyl groups is rapid in both CYP2E1 and CYP2A6 (Table 1). Analysis
of the (kH/kD)obs suppression profiles indicate that the active sites of both enzymes are indeed
rather restricted as significant suppression is observed with m-xylene and p-xylene in
comparison to o-xylene. The metabolic switching from benzylic hydroxylation (m-
methylbenzylalcohol formation) to aromatic hydroxylation (2, 4-dimethylphenol formation)
that is observed with m-xylene suggests that the isotope effect values observed for this
substrate, especially for CYP2A6, might be elevated to some degree since oxidation at an
alternate site can unmask the intrinsic isotope effect [19;37]. The suppression observed with
the m- and p-xylene substrates indicates that reorientation is partially hindered for these
substrates in both CYP2E1 and CYP2A6. Therefore, the spatial limits to unhindered substrate
reorientation can be estimated; this assumes that only one xylene molecule is bound to the
enzyme. Based on the distances between methyl groups, which were determined using
molecular modeling, the spatial limits to unhindered substrate reorientation are in the range of
7 Å2 to 27 Å2 and 14 Å3 to 103 Å3 for two-dimensional and three-dimensional motion,
respectively.
Overall, only minor differences were observed in the suppression profiles for CYP2E1 and
CYP2A6 especially compared to the differences observed in previous comparative studies that
utilized the same technique [21;36]. For two enzymes with a broad overlap in substrate
selectivity it is not especially surprising that they would display similar isotope effect
suppression profiles and that the observed differences in product selectivity in certain cases
could be due to subtle differences in the respective active sites.
Interestingly, for two enzymes that selectively oxidize ‘smaller’ substrates, the isotope effect
suppression for the naphthyl compound, although statistically significant, was not profoundly
different from the (kH/kD)obs for p-xylene (6.04 ± 0.26 versus 5.50 ± 0.47 for CYP2E1 and
5.53 ± 0.19 versus 4.96 ± 0.22 for CYP2A6; p < 0.01 and p < 0.0004 for CYP2E1 and CYP2A6,
respectively). Since the observed isotope effect is dependent on the rate of interchange of protio
and deutero sites these minor differences in (kH/kD)obs suggest that the interchange rates for
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these two substrates are similar even though these compounds span a notable difference in area
(27 Å2 to 51 Å2) and volume (103 Å3 to 271 Å3). Since the intrinsic isotope effects for both
substrates (and isoforms) are only partially suppressed, both substrates rotate rapidly in the
enzyme active sites relative to the rate of substrate oxidation, since the labeled and unlabeled
sites must interchange rapidly in order for an isotope effect to be observed. In the case of p-
xylene this interchange must be occurring within the active since no isotope effect was observed
when the intermolecular competitive isotope effect experiment was conducted using a 1:1
mixture of unlabeled (d0) and labeled (d6) p-xylene. This would mean that p-xylene and
dimethylnaphthalene reorient at approximately the same rate even though dimethylnaphthalene
is much larger than p-xylene and should take up more of the active site volume. That is,
theoretically, the enzyme active site structure should hinder dimethylnaphthalene dynamics to
a greater extent in comparison to p-xylene.
One explanation for only minor differences in isotope effect suppression in the face of a large
increase in spatial requirement is that CYP2A6 and CYP2E1 have some flexibility and may
undergo conformational changes to accommodate the larger naphthyl substrate. These
conformational changes would provide, on average, a ‘roomier’ active site that allows the
protio/deutero interchange rate to be maintained in going from p-xylene to
dimethylnaphthalene. This is consistent with other studies where it has been shown that
CYP2E1 flexibility can be modulated by different substrates [8]. In the case of CYP2A6, the
x-ray crystal structure indicates that it has a restricted active site (260 Å3) that requires a
conformational change to allow the coumarin substrate to enter the active site [38]. The
observation that the intrinsic isotope effect is not completely suppressed for the CYP2E1
mediated hydroxylation of dimethylbiphenyl (kH/kD = 2.28) also provides some support for
the conformational change explanation. That is, CYP2E1 must be accommodating enough to
allow at least some reorientation of this relatively large substrate, albeit at a significantly
reduced rate; whether this reorientation occurs within the active site (a non-dissociative
mechanism) or through a dissociative mechanism is not clear without further experimentation.
Alternatively, uncoupling may produce an increased observed isotope effect which, in the
absence of this branching process, might be completely suppressed [19;39]
There is another explanation for the minor differences in isotope effect suppression observed
for p-xylene compared to dimethylnaphthalene. Hypothetically, the (kH/kD)obs values observed
for the xylene substrates could be generated by the presence of two substrates bound
simultaneously to the CYP instead of a single xylene molecule. That is, kH/kD suppression
(i.e., decreased substrate reorientation rates) with some of the xylene isomers could be caused
by substrate-substrate interactions in addition to interactions with the enzyme active site
structure. Considering the relatively high substrate concentrations used for the experiments (1
mM) this latter scenario seems plausible.
In summary, it is evident that substrate binding for P450 enzymes involves varying degrees of
protein dynamics [5;6;7;8;38]. This flexibility to accommodate various substrates appears to
be an effective and economical characteristic considering the myriad of exogenous compounds
that an organism must oxidize and clear from the system. The strength of intramolecular isotope
effect experiments is that they can provide information regarding the dynamics of substrates
in the active site. Assuming a single substrate is interacting with each enzyme, the data
presented here for p-xylene and dimethylnaphthalene could be interpreted to indicate enzyme
structural dynamics based on the similar orientation rates for these two substrates that differ
significantly in size. On the other hand, in some cases it is possible that (kH/kD)obs is the result
of multiple substrates (e.g., two p-xylene molecules) bound to the enzyme simultaneously. If
this latter case is applicable in some instances, then intramolecular isotope effect experiments
should be especially valuable in the mechanistic investigation of P450 cooperativity, which
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was recently proposed [20]. Experiments that address this hypothesis will be addressed
elsewhere.
On a final note, CYP2E1 and CYP2A6 displayed different degrees of product selectivity for
d3-m-xylene oxidation (Table 2). Therefore d3-m-xylene may represent a new probe substrate
for additional comparative structural studies between CYP2E1 and CYP2A6.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Distances between methyl carbons in selectively deuterium labeled substrates used to assess
substrate dynamics and active site space. The corresponding areas and volumes referenced in
the text were determined by assuming a radius equal to one-half the given distances.
Measurements are theoretical distances determined using Spartan Wavefunction software.
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Figure 2.
Typical chromatogram for the CYP2A6-catalyzed oxidation of m-xylene-α -2H3 (top panel:
incubation with CYP2A6; bottom panel: control with no enzyme). Retention times: 2,4-
dimethylphenol (19.272 min.); m-methylbenzylalcohol (20.068 min).
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Table 1
The observed intramolecular isotope effects for the CYP2E1 and CYP2A6 catalyzed benzylic oxidation of symmetrical
deuterium-labeled substrates and the associated spatial values for two-dimensional and three-dimensional substrate
motion. Numbers in parentheses indicate the number of determinations.
(kH/kD)obs Corresponding Space
Substrate CYP2E1 CYP2A6 Area (Å2) Volume (Å3)
o-xylene-α -2H3 9.03 ± 0.42 (3) 11.46 ± 0.28 (3) 7 14
m-xylene-α -2H3 6.65 ± 0.29 (11) 7.21 ± 0.43 (8) 20 67
p-xylene-α -2H3 6.04 ± 0.26 (9) 5.53 ± 0.19 (7) 27 103
2-2H3, 6-Dimethyl- naphthalene
a 5.50 ± 0.47 (9) 4.96 ± 0.22 (6) 51 271
4-2H3, 4′-dimethyl- biphenyl 2.28 ± 0.18 (3) 1.07 ± 0.07 (3) 81 545
a
p < 0.01 and p < 0.0004 compared to p-xylene values for CYP2E1 and CYP2A6, respectively
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Table 2
Quantitation of metabolic switching (benzylic versus aromatic oxidation) observed for CYP2E1 and CYP2A6 mediated
hydroxylation of d3-m-xylene.
% Products Ratio
Enzyme MBAa DMPb (MBA/DMP)
CYP2E1 96.9 ± 0.3 (6) 3.1 ± 0.3 31.5
CYP2A6 83.6 ± 0.7 (3) 16.4 ± 0.7 5.1
a
m-methylbenzylalcohol.
b
2,4-dimethylphenol. Number in parenthesis indicates the number of determinations
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Table 3
Observed kH/kD for CYP2E1 and CYP2A6 mediated benzylic hydroxylation of p-xylene using a competitive
intermolecular experimental design. Number in parenthesis indicates the number of determinations.
Enzyme (kH/kD)obs
CYP2E1 1.07 ± 0.06 (3)
CYP2A6 1.21 ± 0.03 (3)
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